- Home
- ORIC vs PSEC Comparison
ORIC vs PSEC Comparison
Compare ORIC & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- PSEC
- Stock Information
- Founded
- ORIC 2014
- PSEC 2004
- Country
- ORIC United States
- PSEC United States
- Employees
- ORIC N/A
- PSEC N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- PSEC Finance/Investors Services
- Sector
- ORIC Health Care
- PSEC Finance
- Exchange
- ORIC Nasdaq
- PSEC Nasdaq
- Market Cap
- ORIC 1.1B
- PSEC 1.2B
- IPO Year
- ORIC 2020
- PSEC 2004
- Fundamental
- Price
- ORIC $13.16
- PSEC $2.66
- Analyst Decision
- ORIC Strong Buy
- PSEC Sell
- Analyst Count
- ORIC 8
- PSEC 1
- Target Price
- ORIC $16.57
- PSEC $2.50
- AVG Volume (30 Days)
- ORIC 1.5M
- PSEC 3.5M
- Earning Date
- ORIC 11-06-2025
- PSEC 11-07-2025
- Dividend Yield
- ORIC N/A
- PSEC 20.30%
- EPS Growth
- ORIC N/A
- PSEC N/A
- EPS
- ORIC N/A
- PSEC N/A
- Revenue
- ORIC N/A
- PSEC $719,436,000.00
- Revenue This Year
- ORIC N/A
- PSEC N/A
- Revenue Next Year
- ORIC N/A
- PSEC N/A
- P/E Ratio
- ORIC N/A
- PSEC N/A
- Revenue Growth
- ORIC N/A
- PSEC N/A
- 52 Week Low
- ORIC $3.90
- PSEC $2.57
- 52 Week High
- ORIC $14.93
- PSEC $5.28
- Technical
- Relative Strength Index (RSI)
- ORIC 54.79
- PSEC 42.38
- Support Level
- ORIC $12.75
- PSEC $2.59
- Resistance Level
- ORIC $13.80
- PSEC $2.82
- Average True Range (ATR)
- ORIC 0.72
- PSEC 0.07
- MACD
- ORIC -0.08
- PSEC -0.01
- Stochastic Oscillator
- ORIC 58.97
- PSEC 26.92
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.